Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Xiaoming, Xing"'
Autor:
Litong Liu, Ping Wang, Cheng Guo, Li Song, Lifang Chen, Hongbing Qi, Yangyang Zheng, Xiaoming Xing, Chengqin Wang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Tongue squamous cell carcinoma (TSCC) is one of the most common malignant tumors with high mortality and poor prognosis. Its incidence rate is increasing gradually. Tumor necrosis factor receptor-associated factor interacting prot
Externí odkaz:
https://doaj.org/article/d997c24aef0045ee82d0e9d1fb4d1a90
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundIdiopathic pulmonary fibrosis (IPF) is a lethal lung disease characterized by progressive fibrosis, leading to impaired gas exchange and high mortality. The etiology of IPF is complex, with potential links to autoimmune disorders such as hy
Externí odkaz:
https://doaj.org/article/826154bc4671428d8afe9bca18242d34
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Targeted therapy for malignancies has developed rapidly in recent years, benefiting patients harboring genetic mutations sensitive to relevant tyrosine kinase inhibitors (TKIs). With the development of targeted sequencing techniques, an incr
Externí odkaz:
https://doaj.org/article/2961009cac3b441c8e633c54283c3b3f
Autor:
Yaolin Song, Wenwen Ran, Huiqing Jia, Qin Yao, Guangqi Li, Yang Chen, Xiaonan Wang, Yujing Xiao, Mengqi Sun, Xiao Lu, Xiaoming Xing
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e23684- (2024)
Background: Ovarian cancer is the leading cause of death from gynecological malignancies. Investigating the HRR-related gene status, notably BRCA1/2 in different regions and populations is of great significance for formulating accurate target therapy
Externí odkaz:
https://doaj.org/article/bbab7fb40ea74f4cbbc3008f38e8cde5
Autor:
Xiangyan Zhang, Geru Tao, Jie Jiang, Tingting Qu, Shuchao Zhao, Ping Xu, Ya’nan Zhao, Xiaoming Xing, Shucun Qin
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Phosphoenolpyruvate carboxykinase 1 (PCK1) is the rate-limiting enzyme in gluconeogenesis. PCK1 is considered an anti-oncogene in several human cancers. In this study, we aimed to determine the functions of PCK1 in colorectal cancer (CRC). P
Externí odkaz:
https://doaj.org/article/d0591e283c3e4ebea8f0f3ec6fa6cd05
Publikováno v:
In International Journal of Biochemistry and Cell Biology April 2023 157
Autor:
Cun Liu, Ye Li, Xiaoming Xing, Jing Zhuang, Jigang Wang, Chunyan Wang, Lujun Zhang, Lijuan Liu, Fubin Feng, Huayao Li, Chundi Gao, Yang Yu, Jingyang Liu, Changgang Sun
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 28, Iss , Pp 670-684 (2022)
Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We hypothesized that molecular-based phenotypic characterization of TNBC tumors and th
Externí odkaz:
https://doaj.org/article/9c0a2c20ba554e7391414377cb2394a1
Autor:
Mengmeng Wang, Xin Ren, Ge Wang, Xiaomin Sun, Shifeng Tang, Baogang Zhang, Xiaoming Xing, Wenfeng Zhang, Guojun Gao, Jing Du, Shukun Zhang, Lijuan Liu, Xia Zheng, Zhenkun Zhang, Changgang Sun
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background There are differences in survival between high-and low-grade Upper Tract Urothelial Carcinoma (UTUC). Our study aimed to develop a nomogram to predict overall survival (OS) of patients with high- and low-grade UTUC after tumor res
Externí odkaz:
https://doaj.org/article/965a403f19dd4c1cba93ace0d48ada7d
Autor:
Huihong Meng1 linghong212@163.com, Xiaoming Xing1, Chao Zhang1, Jing Zhao1, Cuijian Ren1, Yonggang Liu1
Publikováno v:
Pakistan Journal of Medical Sciences. May/Jun2023, Vol. 39 Issue 3, p677-681. 5p.
Autor:
Dan Li, Li Ding, Wenwen Ran, Yan Huang, Guangqi Li, Chengqin Wang, Yujing Xiao, Xiaonan Wang, Dongliang Lin, Xiaoming Xing
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2580-2589 (2020)
Background The status of targeted genes and the association between targeted genes and clinicopathological features in Chinese lung cancer patients remains to be elucidated. Methods The status of 10 targeted genes was evaluated by next‐generation s
Externí odkaz:
https://doaj.org/article/45c6b4008b554a628401571f4ae26155